NCT02243709View on ClinicalTrials.gov

Mifepristone for the Prevention of Relapses of Alcohol Drinking

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 21, 2021

Study Completion Date

December 21, 2021

Conditions
Alcohol Use Disorders (AUD)
Interventions
DRUG

Mifepristone 600-mg/day or placebo for a week

600-mg of mifepristone for a week, compared to placebo for a week, in a stress-induced condition triggered by a single dose of 32.4 mg of yohimbine

Trial Locations (1)

02912

Center for Alcohol and Addiction Studies, Brown University, Providence

Sponsors

Lead Sponsor

Brown University
All Listed Sponsors
lead

Brown University

OTHER